Related Experiment Video

Updated: Apr 17, 2026

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
13:48

Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound

Published on: April 21, 2023

2.2K

State-of-the-art treatment of common femoral artery disease

B Nasr1, A Kaladji, P A Vent

  • 1CHU de Brest, Service de Chirurgie Vasculaire, Brest, France - yann.goueffic@chu-nantes.fr.

The Journal of Cardiovascular Surgery
|February 4, 2015
PubMed

Insights

Common femoral artery (CFA) disease, a cause of peripheral artery disease (PAD), now has advanced treatment options beyond surgery. This review details current endovascular and open surgical procedures for CFA disease management.

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Peripheral Artery Disease

Background:

  • Atherosclerotic common femoral artery (CFA) disease is a significant cause of symptomatic peripheral artery disease (PAD).
  • Historically, surgical intervention was the primary treatment for CFA disease.
  • Recent therapeutic advancements have expanded treatment modalities.

Purpose of the Study:

  • To summarize recent therapeutic updates for common femoral artery (CFA) disease.
  • To describe current endovascular and open surgical procedures for CFA disease.

Main Methods:

  • Review of current literature on CFA disease treatment.
  • Synthesis of information on medical, endovascular, and open surgical approaches.
  • Description of established and emerging therapeutic strategies.

Main Results:

  • A broad range of treatment options are now available for CFA disease.
  • Endovascular techniques offer less invasive alternatives to open surgery.
  • Open surgical procedures remain a viable option for complex cases.

Conclusions:

  • The management of CFA disease has evolved significantly with new therapeutic options.
  • Both endovascular and open surgical approaches are integral to modern CFA disease treatment.
  • Personalized treatment strategies are essential for optimal patient outcomes in PAD.

More Related Videos

Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits07:34

Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits

Published on: June 2, 2019

10.5K
Murine Model of Femoral Artery Wire Injury with Implantation of a Perivascular Drug Delivery Patch07:05

Murine Model of Femoral Artery Wire Injury with Implantation of a Perivascular Drug Delivery Patch

Published on: February 10, 2015

19.2K

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
626
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
613
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
608
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
463
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
435
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
623